Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Eliasson B"" wg kryterium: Autor


Tytuł :
Real-World Costs of Continuous Insulin Pump Therapy and Multiple Daily Injections for Type 1 Diabetes: A Population-Based and Propensity-Matched Cohort From the Swedish National Diabetes Register.
Autorzy :
Toresson Grip E; Swedish Institute for Health Economics, Lund, Sweden.
Svensson AM; National Diabetes Register, Centre of Registers in Västra Götaland, Gothenburg, Sweden.
Miftaraj M; National Diabetes Register, Centre of Registers in Västra Götaland, Gothenburg, Sweden.
Eliasson B; National Diabetes Register, Centre of Registers in Västra Götaland, Gothenburg, Sweden.; Department of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden.
Franzén S; National Diabetes Register, Centre of Registers in Västra Götaland, Gothenburg, Sweden.
Gudbjörnsdottir S; National Diabetes Register, Centre of Registers in Västra Götaland, Gothenburg, Sweden.; Department of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden.
Steen Carlsson K; Swedish Institute for Health Economics, Lund, Sweden .; Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden.
Pokaż więcej
Źródło :
Diabetes care [Diabetes Care] 2019 Apr; Vol. 42 (4), pp. 545-552. Date of Electronic Publication: 2019 Jan 31.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Costs*/statistics & numerical data
Diabetes Mellitus, Type 1/*drug therapy
Diabetes Mellitus, Type 1/*economics
Insulin/*administration & dosage
Insulin/*economics
Insulin Infusion Systems/*economics
Adult ; Case-Control Studies ; Cohort Studies ; Diabetes Mellitus, Type 1/epidemiology ; Drug Administration Schedule ; Female ; Follow-Up Studies ; Health Care Costs/statistics & numerical data ; Humans ; Hypoglycemic Agents/administration & dosage ; Hypoglycemic Agents/economics ; Injections, Subcutaneous/economics ; Insulin/adverse effects ; Insulin Infusion Systems/statistics & numerical data ; Male ; Middle Aged ; Registries ; Sweden/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Metabolic characteristics of individuals at a high risk of type 2 diabetes - a comparative cross-sectional study.
Autorzy :
Henninger J; The Lundberg Laboratory for Diabetes Research, Department of Molecular and Clinical Medicine, the Sahlgrenska Academy at the University of Gothenburg, 413 45, Gothenburg, Sweden. .
Rawshani A; The Lundberg Laboratory for Diabetes Research, Department of Molecular and Clinical Medicine, the Sahlgrenska Academy at the University of Gothenburg, 413 45, Gothenburg, Sweden.
Hammarstedt A; The Lundberg Laboratory for Diabetes Research, Department of Molecular and Clinical Medicine, the Sahlgrenska Academy at the University of Gothenburg, 413 45, Gothenburg, Sweden.
Eliasson B; The Lundberg Laboratory for Diabetes Research, Department of Molecular and Clinical Medicine, the Sahlgrenska Academy at the University of Gothenburg, 413 45, Gothenburg, Sweden.
Pokaż więcej
Źródło :
BMC endocrine disorders [BMC Endocr Disord] 2017 Jul 14; Vol. 17 (1), pp. 40. Date of Electronic Publication: 2017 Jul 14.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Body Mass Index*
Insulin Resistance*
Biomarkers/*metabolism
Diabetes Mellitus, Type 2/*diagnosis
Glucose Intolerance/*diagnosis
Insulin/*metabolism
Adult ; Blood Glucose/metabolism ; Cross-Sectional Studies ; Diabetes Mellitus, Type 2/epidemiology ; Diabetes Mellitus, Type 2/metabolism ; Family ; Female ; Follow-Up Studies ; Glucose Intolerance/epidemiology ; Glucose Intolerance/metabolism ; Humans ; Insulin Secretion ; Male ; Prognosis
Czasopismo naukowe
Tytuł :
Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese men.
Autorzy :
Matikainen N; Research Programs Unit, Diabetes and Obesity, University of Helsinki, Helsinki University Hospital, Helsinki, Finland; Endocrinology, Abdominal Center, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland. Electronic address: .
Söderlund S; Research Programs Unit, Diabetes and Obesity, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.
Björnson E; Department of Molecular and Clinical Medicine/Wallenberg Laboratory, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
Bogl LH; Research Programs Unit, Diabetes and Obesity, University of Helsinki, Helsinki University Hospital, Helsinki, Finland; Institute for Molecular Medicine FIMM, Helsinki, Finland; Department of Public Health, University of Helsinki, Helsinki, Finland.
Pietiläinen KH; Research Programs Unit, Diabetes and Obesity, University of Helsinki, Helsinki University Hospital, Helsinki, Finland; Endocrinology, Abdominal Center, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.
Hakkarainen A; Radiology, HUS Medical Imaging Center, Helsinki University Hospital, University of Helsinki, Finland.
Lundbom N; Radiology, HUS Medical Imaging Center, Helsinki University Hospital, University of Helsinki, Finland.
Eliasson B; Department of Molecular and Clinical Medicine/Wallenberg Laboratory, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
Räsänen SM; Research Programs Unit, Diabetes and Obesity, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.
Rivellese A; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
Patti L; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
Prinster A; Biostructure and Bioimaging Institute, National Research Council, Naples, Italy.
Riccardi G; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
Després JP; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec City, Québec, Canada.
Alméras N; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec City, Québec, Canada.
Holst JJ; NNF Centre for Basic Metabolic Research, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Deacon CF; NNF Centre for Basic Metabolic Research, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Borén J; Department of Molecular and Clinical Medicine/Wallenberg Laboratory, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
Taskinen MR; Research Programs Unit, Diabetes and Obesity, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.
Pokaż więcej
Źródło :
Nutrition, metabolism, and cardiovascular diseases : NMCD [Nutr Metab Cardiovasc Dis] 2017 Jun; Vol. 27 (6), pp. 534-542. Date of Electronic Publication: 2017 Mar 18.
Typ publikacji :
Clinical Trial; Journal Article; Multicenter Study
MeSH Terms :
Glucose Tolerance Test*
Beverages/*adverse effects
Blood Glucose/*metabolism
Dietary Carbohydrates/*adverse effects
Fructose/*adverse effects
Gastrointestinal Hormones/*blood
Insulin/*blood
Metabolic Syndrome/*blood
Obesity/*blood
Adult ; Aged ; Biomarkers/blood ; Dietary Carbohydrates/administration & dosage ; Dietary Carbohydrates/blood ; Drinking ; Europe ; Fructose/administration & dosage ; Fructose/blood ; Humans ; Insulin Resistance ; Liver/metabolism ; Liver/pathology ; Male ; Metabolic Syndrome/diagnosis ; Metabolic Syndrome/physiopathology ; Middle Aged ; Obesity/diagnosis ; Obesity/physiopathology ; Postprandial Period ; Predictive Value of Tests ; Quebec ; Time Factors ; Triglycerides/blood ; Weight Gain ; Young Adult
Czasopismo naukowe
Tytuł :
Cephalic phase of insulin secretion in response to a meal is unrelated to family history of type 2 diabetes.
Autorzy :
Eliasson B; The Lundberg Laboratory for Diabetes Research, Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Rawshani A; The Lundberg Laboratory for Diabetes Research, Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Axelsen M; Department of Clinical Nutrition, Institute of Medicine; Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Hammarstedt A; The Lundberg Laboratory for Diabetes Research, Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Smith U; The Lundberg Laboratory for Diabetes Research, Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2017 Mar 13; Vol. 12 (3), pp. e0173654. Date of Electronic Publication: 2017 Mar 13 (Print Publication: 2017).
Typ publikacji :
Journal Article
MeSH Terms :
Diabetes Mellitus, Type 2*
Insulin/*metabolism
Adult ; C-Peptide/metabolism ; Case-Control Studies ; Eating ; Fasting/physiology ; Glucose Intolerance ; Glucose Tolerance Test ; Humans ; Insulin Secretion ; Male ; Meals ; Middle Aged ; Pedigree
Czasopismo naukowe
Tytuł :
Metabolic predictors of impaired glucose tolerance and type 2 diabetes in a predisposed population--A prospective cohort study.
Autorzy :
Henninger J; The Lundberg Laboratory for Diabetes Research, Sahlgrenska University Hospital, 413 45, Gothenburg, Sweden. .
Hammarstedt A; The Lundberg Laboratory for Diabetes Research, Department of Molecular and Clinical Medicine, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. .
Rawshani A; The Lundberg Laboratory for Diabetes Research, Department of Molecular and Clinical Medicine, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. .
Eliasson B; The Lundberg Laboratory for Diabetes Research, Department of Molecular and Clinical Medicine, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. bjorn.eliasson@gu.se.
Pokaż więcej
Źródło :
BMC endocrine disorders [BMC Endocr Disord] 2015 Sep 25; Vol. 15, pp. 51. Date of Electronic Publication: 2015 Sep 25.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Insulin Resistance*
Biomarkers/*analysis
Blood Glucose/*analysis
Diabetes Mellitus, Type 2/*diagnosis
Glucose Intolerance/*diagnosis
Insulin/*metabolism
Adolescent ; Adult ; Body Mass Index ; Diabetes Mellitus, Type 2/epidemiology ; Diabetes Mellitus, Type 2/metabolism ; Female ; Follow-Up Studies ; Glucose Intolerance/epidemiology ; Glucose Intolerance/metabolism ; Glucose Tolerance Test ; Humans ; Insulin Secretion ; Insulin-Secreting Cells/metabolism ; Insulin-Secreting Cells/pathology ; Male ; Prospective Studies ; Risk Factors ; Young Adult
Czasopismo naukowe
Tytuł :
Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational study.
Autorzy :
Steineck I; Department of Endocrinology, Aarhus University Hospital, Aarhus Denmark .
Cederholm J; Department of Public Health and Caring Sciences/Family and Preventive Medicine, Uppsala University, Uppsala, Sweden.
Eliasson B; Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden.
Rawshani A; National Diabetes Register, Centre of Registers, Gothenburg, Sweden.
Eeg-Olofsson K; Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden.
Svensson AM; National Diabetes Register, Centre of Registers, Gothenburg, Sweden.
Zethelius B; Department of Public Health and Caring Sciences/Geriatrics, Uppsala University, Uppsala, Sweden Medical Products Agency, Uppsala, Sweden.
Avdic T; National Diabetes Register, Centre of Registers, Gothenburg, Sweden.
Landin-Olsson M; Department of Clinical Science, Lund University, Lund, Sweden.
Jendle J; Faculty of Health Sciences and Medicine, Örebro University, Örebro, Sweden.
Gudbjörnsdóttir S; Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden National Diabetes Register, Centre of Registers, Gothenburg, Sweden.
Pokaż więcej
Corporate Authors :
Swedish National Diabetes Register
Źródło :
BMJ (Clinical research ed.) [BMJ] 2015 Jun 22; Vol. 350, pp. h3234. Date of Electronic Publication: 2015 Jun 22.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Injections*
Insulin Infusion Systems*
Cardiovascular Diseases/*prevention & control
Diabetes Mellitus, Type 1/*drug therapy
Diabetic Angiopathies/*prevention & control
Hypoglycemic Agents/*administration & dosage
Insulin/*administration & dosage
Blood Pressure ; Cardiovascular Diseases/blood ; Cardiovascular Diseases/mortality ; Diabetes Mellitus, Type 1/blood ; Diabetes Mellitus, Type 1/mortality ; Diabetic Angiopathies/blood ; Diabetic Angiopathies/mortality ; Disease Progression ; Follow-Up Studies ; Glycated Hemoglobin A/drug effects ; Humans ; Patient Education as Topic ; Registries ; Risk Factors ; Sweden/epidemiology
Czasopismo naukowe
Tytuł :
Long-term mortality in patients with type 2 diabetes undergoing coronary angiography: the impact of glucose-lowering treatment.
Autorzy :
Saleh N; Cardiology Unit, Department of Medicine, Karolinska University Hospital, N3:06, Solna, 171 76, Stockholm, Sweden.
Petursson P
Lagerqvist B
Skúladóttir H
Svensson A
Eliasson B
Gudbjörnsdottir S
Eeg-Olofsson K
Norhammar A
Pokaż więcej
Źródło :
Diabetologia [Diabetologia] 2012 Aug; Vol. 55 (8), pp. 2109-17. Date of Electronic Publication: 2012 May 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Coronary Angiography/*statistics & numerical data
Coronary Disease/*mortality
Diabetes Mellitus, Type 2/*mortality
Diabetic Angiopathies/*mortality
Diet Therapy/*statistics & numerical data
Hypoglycemic Agents/*therapeutic use
Insulin/*therapeutic use
Aged ; Comorbidity ; Coronary Angiography/mortality ; Coronary Disease/etiology ; Coronary Disease/therapy ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/therapy ; Diabetic Angiopathies/etiology ; Diabetic Angiopathies/therapy ; Female ; Follow-Up Studies ; Humans ; Hypoglycemic Agents/adverse effects ; Insulin/adverse effects ; Male ; Retrospective Studies ; Survival Analysis ; Sweden/epidemiology ; Time Factors
Czasopismo naukowe
Tytuł :
Glucose-lowering treatment and clinical results in 163 121 patients with type 2 diabetes: an observational study from the Swedish national diabetes register.
Autorzy :
Ekström N; Department of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. />Miftaraj M
Svensson AM
Andersson Sundell K
Cederholm J
Zethelius B
Gudbjörnsdottir S
Eliasson B
Pokaż więcej
Źródło :
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2012 Aug; Vol. 14 (8), pp. 717-26. Date of Electronic Publication: 2012 Apr 01.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cardiovascular Diseases/*drug therapy
Diabetes Mellitus, Type 2/*drug therapy
Diabetic Angiopathies/*drug therapy
Hypoglycemic Agents/*therapeutic use
Insulin/*therapeutic use
Metformin/*therapeutic use
Aged ; Biomarkers/blood ; Blood Glucose/metabolism ; Cardiovascular Diseases/blood ; Cardiovascular Diseases/epidemiology ; Cross-Sectional Studies ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/epidemiology ; Diabetic Angiopathies/blood ; Diabetic Angiopathies/epidemiology ; Female ; Glycated Hemoglobin A/metabolism ; Humans ; Insulin/blood ; Male ; Middle Aged ; Registries ; Risk Factors ; Sweden/epidemiology ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
One-year treatment with exenatide vs. insulin glargine: effects on postprandial glycemia, lipid profiles, and oxidative stress.
Autorzy :
Bunck MC; Department of Internal Medicine, Section of Endocrinology, Diabetes Center, VU University Medical Center, Amsterdam, The Netherlands.
Cornér A
Eliasson B
Heine RJ
Shaginian RM
Wu Y
Yan P
Smith U
Yki-Järvinen H
Diamant M
Taskinen MR
Pokaż więcej
Źródło :
Atherosclerosis [Atherosclerosis] 2010 Sep; Vol. 212 (1), pp. 223-9. Date of Electronic Publication: 2010 Apr 29.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Blood Glucose/*drug effects
Diabetes Mellitus, Type 2/*drug therapy
Hyperlipidemias/*prevention & control
Hypoglycemic Agents/*administration & dosage
Insulin/*analogs & derivatives
Lipids/*blood
Oxidative Stress/*drug effects
Peptides/*administration & dosage
Venoms/*administration & dosage
Apolipoprotein B-48/blood ; Biomarkers/blood ; Blood Glucose/metabolism ; Cholesterol, VLDL/blood ; Diabetes Mellitus, Type 2/blood ; Drug Administration Schedule ; Europe ; Exenatide ; Fatty Acids, Nonesterified/blood ; Female ; Glycated Hemoglobin A/metabolism ; Humans ; Hyperlipidemias/blood ; Hyperlipidemias/etiology ; Hypoglycemic Agents/adverse effects ; Insulin/administration & dosage ; Insulin/adverse effects ; Insulin Glargine ; Insulin, Long-Acting ; Lipoproteins, LDL/blood ; Male ; Malondialdehyde/blood ; Middle Aged ; Peptides/adverse effects ; Postprandial Period ; Time Factors ; Treatment Outcome ; Triglycerides/blood ; Venoms/adverse effects
Czasopismo naukowe
Tytuł :
One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial.
Autorzy :
Bunck MC; Department of Endocrinology, Diabetes Center, VU University Medical Center, Amsterdam, the Netherlands.
Diamant M
Cornér A
Eliasson B
Malloy JL
Shaginian RM
Deng W
Kendall DM
Taskinen MR
Smith U
Yki-Järvinen H
Heine RJ
Pokaż więcej
Źródło :
Diabetes care [Diabetes Care] 2009 May; Vol. 32 (5), pp. 762-8. Date of Electronic Publication: 2009 Feb 05.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Diabetes Mellitus, Type 2/*drug therapy
Hypoglycemic Agents/*therapeutic use
Insulin/*analogs & derivatives
Insulin/*metabolism
Insulin-Secreting Cells/*physiology
Metformin/*therapeutic use
Peptides/*therapeutic use
Venoms/*therapeutic use
Arginine/pharmacology ; Blood Glucose/metabolism ; Body Mass Index ; C-Peptide/blood ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/physiopathology ; Exenatide ; Female ; Glycated Hemoglobin A/metabolism ; Humans ; Insulin/therapeutic use ; Insulin Glargine ; Insulin Secretion ; Insulin, Long-Acting ; Insulin-Secreting Cells/drug effects ; Kinetics ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
The effect of insulin lispro on glycemic control in a large patient cohort.
Autorzy :
Lind M; Department of Medicine, Uddevalla Hospital, Sweden. />Fahlén M
Happich M
Odén A
Eliasson B
Pokaż więcej
Źródło :
Diabetes technology & therapeutics [Diabetes Technol Ther] 2009 Jan; Vol. 11 (1), pp. 51-6.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Blood Glucose/*metabolism
Diabetes Mellitus, Type 1/*drug therapy
Insulin/*analogs & derivatives
Cohort Studies ; Diabetes Mellitus, Type 1/blood ; Female ; Follow-Up Studies ; Glycated Hemoglobin A/drug effects ; Glycated Hemoglobin A/metabolism ; Homeostasis ; Humans ; Hypoglycemic Agents/therapeutic use ; Insulin/therapeutic use ; Insulin Lispro ; Insulin, Isophane/therapeutic use ; Male ; Middle Aged ; Sweden
Czasopismo naukowe
Tytuł :
[What is really an optimal treatment in type 2 diabetes? New studies call for reflection].
Autorzy :
Nilsson PM; Institutionen för kliniska vetenskaper, Universitetssjukhuset MAS, Malmö. />Eliasson B
Pokaż więcej
Transliterated Title :
Vad ar egentligen en optimal behandling vid typ 2-diabetes? Nya studier manar till eftertanke.
Źródło :
Lakartidningen [Lakartidningen] 2008 Apr 2-8; Vol. 105 (14), pp. 985-6.
Typ publikacji :
Journal Article
MeSH Terms :
Diabetes Mellitus, Type 2/*drug therapy
Hypoglycemic Agents/*therapeutic use
Insulin/*therapeutic use
Cardiovascular Diseases/etiology ; Diabetes Complications/prevention & control ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/complications ; Glycated Hemoglobin A/analysis ; Humans ; Risk Factors
Czasopismo naukowe
Tytuł :
A method to predict the metabolic effects of changes in insulin treatment in subgroups of a large population based patient cohort.
Autorzy :
Osterbrand M; Department of Medicine, Uddevalla Hospital, Uddevalla 451 80, Sweden. />Fahlén M
Odén A
Eliasson B
Pokaż więcej
Źródło :
European journal of epidemiology [Eur J Epidemiol] 2007; Vol. 22 (3), pp. 151-7. Date of Electronic Publication: 2007 Feb 06.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Diabetes Mellitus, Type 1/*drug therapy
Diabetes Mellitus, Type 2/*drug therapy
Hypoglycemic Agents/*therapeutic use
Insulin/*analogs & derivatives
Insulin, Isophane/*therapeutic use
Body Mass Index ; Case-Control Studies ; Female ; Glycated Hemoglobin A/analysis ; Humans ; Hypoglycemic Agents/administration & dosage ; Insulin/administration & dosage ; Insulin/therapeutic use ; Insulin Glargine ; Insulin, Isophane/administration & dosage ; Insulin, Long-Acting ; Male ; Middle Aged ; Regression Analysis ; Retrospective Studies ; Sensitivity and Specificity ; Sex Factors
Czasopismo naukowe
Tytuł :
Optimization of basal insulin delivery in Type 1 diabetes: a retrospective study on the use of continuous subcutaneous insulin infusion and insulin glargine.
Autorzy :
Fahlén M; Department of Medicine, Hospital Kungälv, Kungälv, Sweden. />Eliasson B
Odén A
Pokaż więcej
Źródło :
Diabetic medicine : a journal of the British Diabetic Association [Diabet Med] 2005 Apr; Vol. 22 (4), pp. 382-6.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study
MeSH Terms :
Insulin Infusion Systems*
Diabetes Mellitus, Type 1/*drug therapy
Hypoglycemic Agents/*administration & dosage
Insulin/*administration & dosage
Insulin/*analogs & derivatives
Adult ; Blood Glucose/metabolism ; Diabetes Mellitus, Type 1/blood ; Drug Administration Schedule ; Female ; Glycated Hemoglobin A/metabolism ; Humans ; Hypoglycemic Agents/therapeutic use ; Infusion Pumps, Implantable ; Insulin/therapeutic use ; Insulin Glargine ; Insulin, Long-Acting ; Male ; Middle Aged ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Impaired phosphorylation and insulin-stimulated translocation to the plasma membrane of protein kinase B/Akt in adipocytes from Type II diabetic subjects.
Autorzy :
Carvalho E; Department of Internal Medicine, Gothenburg University, Sahlgrenska University Hospital, Sweden.
Eliasson B
Wesslau C
Smith U
Pokaż więcej
Źródło :
Diabetologia [Diabetologia] 2000 Sep; Vol. 43 (9), pp. 1107-15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Protein-Serine-Threonine Kinases*
Adipocytes/*enzymology
Cell Membrane/*enzymology
Diabetes Mellitus, Type 2/*enzymology
Insulin/*pharmacology
Proto-Oncogene Proteins/*metabolism
Adipocytes/drug effects ; Adipose Tissue/enzymology ; Humans ; In Vitro Techniques ; Microsomes/enzymology ; Phosphorylation ; Protein Transport ; Proto-Oncogene Proteins/genetics ; Proto-Oncogene Proteins c-akt ; RNA, Messenger/genetics ; Transcription, Genetic
Czasopismo naukowe
Tytuł :
Insulin signaling and action in fat cells: associations with insulin resistance and type 2 diabetes.
Autorzy :
Smith U; Lundberg Laboratory for Diabetes Research, Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden. />Axelsen M
Carvalho E
Eliasson B
Jansson PA
Wesslau C
Pokaż więcej
Źródło :
Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 1999 Nov 18; Vol. 892, pp. 119-26.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Insulin Resistance*
Signal Transduction*
Adipocytes/*metabolism
Diabetes Mellitus, Type 2/*metabolism
Insulin/*metabolism
Dietary Fats/metabolism ; Humans ; Liver/metabolism ; Muscles/metabolism
Czasopismo naukowe
Tytuł :
Smoking cessation improves insulin sensitivity in healthy middle-aged men.
Autorzy :
Eliasson B; Lundberg Laboratory for Diabetes Research, Department of Medicine, Sahlgrenska University Hospital, Göteborg, Sweden.
Attvall S
Taskinen MR
Smith U
Pokaż więcej
Źródło :
European journal of clinical investigation [Eur J Clin Invest] 1997 May; Vol. 27 (5), pp. 450-6.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Insulin Resistance*
Smoking Cessation*
Insulin/*blood
Smoking/*adverse effects
Adult ; Apolipoprotein A-I/metabolism ; Apolipoprotein A-II/metabolism ; Blood Glucose/metabolism ; Body Mass Index ; Cholesterol, HDL/blood ; Cotinine/blood ; Glucose Clamp Technique ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance.
Autorzy :
Eliasson B; Department of Internal Medicine, Sahlgrenska University Hospital, Göteborg, Sweden. bjorn.eliasson@medicine.gu.se
Taskinen MR
Smith U
Pokaż więcej
Źródło :
Circulation [Circulation] 1996 Sep 01; Vol. 94 (5), pp. 878-81.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Insulin Resistance*
Insulin/*blood
Nicotine/*administration & dosage
Adult ; C-Peptide/analysis ; Cotinine/blood ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Effects of insulin and beta-adrenergic blockade on the migrating motor complex in humans.
Autorzy :
Björnsson ES; Division of Gastroenterology, University of Göteborg, Sahlgren's Hospital, Sweden.
Urbanavicius V
Eliasson B
Attvall S
Smith U
Abrahamsson H
Pokaż więcej
Źródło :
Scandinavian journal of gastroenterology [Scand J Gastroenterol] 1995 Mar; Vol. 30 (3), pp. 219-24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Duodenum/*physiology
Insulin/*pharmacology
Myoelectric Complex, Migrating/*drug effects
Propranolol/*pharmacology
Receptors, Adrenergic, beta/*physiology
Adult ; Female ; Humans ; Male ; Myoelectric Complex, Migrating/physiology ; Receptors, Adrenergic, beta/drug effects
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies